Risk Factors for Pneumocystis Jirovecii Pneumonia Among Kidney Transplant Recipients in Southeast France: A 10 Years Case‐Control Study
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70595 ↗At a glance
Journal article in Clinical Transplantation, 2026. Written by Solenne Hulot and 9 co-authors. Institution: IHU-Méditerranée Infection, AP-HM, Marseille, France. Major MEDLINE topics: Kidney Transplantation, Pneumonia, Pneumocystis, Pneumocystis carinii, Postoperative Complications. Cited 2 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: French Government managed by the National Research Agency.
Abstract (original language)
Background
Pneumocystis jirovecii is an opportunistic fungus responsible for Pneumocystis pneumonia (PJP) in hosts with impaired cell‐mediated immunity, particularly solid organ transplant recipients. The aim of our study was to identify risk factors associated with PJP in kidney transplant recipients (KTRs).
Methods
We conducted a single‐center, retrospective, case‐control study (1 case per 2 controls) of KTRs from May 2014 to May 2024. Cases were defined as KTRs with a confirmed diagnosis of PJP, while controls were matched on transplant and hospitalization dates (±3 months) and had not developed PJP during the follow‐up period. Statistical analysis was performed using conditional logistic regression models to examine potential risk factors for PJP, with a forward stepwise selection procedure to identify significant variables.
Results
A total of 37 KTRs with PJP and 74 matched controls were included. The median time from transplantation to diagnosis was 60 months. Two cases occurred before prophylaxis was discontinued, followed by 11 cases within the next six months. Baseline characteristics were similar between cases and controls. The number of day hospital or outpatient visits in the year prior to inclusion was significantly higher in cases than in controls (mean 11.11 vs. 8.89 visits, p = 0.04). Severe lymphopenia (
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- IHU-Méditerranée Infection, AP-HM, Marseille, France.
- Centre De Néphrologie et Transplantation Rénale, Hôpital Conception, Assistance Publique Hôpitaux de Marseille, Marseille, France.
- RITMES, Aix-Marseille Université, AP-HM, SSA, Marseille, France.
- MINES, Aix-Marseille Univ, IRD, SSA, Marseille, France.
- Service De Prévention du Risque Infectieux (LESPRI), CLIN, AP-HM Hôpitaux Universitaires De Marseille, Marseille, France.
- Faculté De pharmacie, C2VN, Aix Marseille Univ, INSERM, INRAE, Marseille, France.
Funding
- French Government managed by the National Research Agency
Cite
APA
Hulot, S., Godefroy, R., Doudier, B., Delorme, L., Cortaredona, S., Sartor, C., L'Ollivier, C., Burtey, S., Moal, V., & Cassir, N. (2026). Risk Factors for Pneumocystis Jirovecii Pneumonia Among Kidney Transplant Recipients in Southeast France: A 10 Years Case‐Control Study. Clinical Transplantation. https://doi.org/10.1111/ctr.70595
Vancouver
Hulot S, Godefroy R, Doudier B, Delorme L, Cortaredona S, Sartor C, et al. Risk Factors for Pneumocystis Jirovecii Pneumonia Among Kidney Transplant Recipients in Southeast France: A 10 Years Case‐Control Study. Clinical Transplantation. 2026. doi:10.1111/ctr.70595
BibTeX
@article{Hulot2026,
author = {Hulot, Solenne and Godefroy, Raphaël and Doudier, Barbara and Delorme, Léa and Cortaredona, Sébastien and Sartor, Catherine and L'Ollivier, Coralie and Burtey, Stéphane and Moal, Valérie and Cassir, Nadim},
title = {Risk Factors for Pneumocystis Jirovecii Pneumonia Among Kidney Transplant Recipients in Southeast France: A 10 Years Case‐Control Study},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70595}
}
EUVIMED